Mesenchymal stem cells in Parkinson’s disease: Motor and nonmotor symptoms in the early posttransplant period

BACKGROUND: Treatment of patients with Parkinson disease (PD) using autologous mesenchymal stem cells (MSCs) is a promising method to influence the pathogenesis of the disease. The aim of this study was to assess the immediate results of the introduction of MSCs on the effectiveness of motor and non...

Descripción completa

Detalles Bibliográficos
Autores principales: Boika, Aliaksandr, Aleinikava, Natallia, Chyzhyk, Veranika, Zafranskaya, Marina, Nizheharodava, Darya, Ponomarev, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771400/
https://www.ncbi.nlm.nih.gov/pubmed/33408914
http://dx.doi.org/10.25259/SNI_233_2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771400/
https://www.ncbi.nlm.nih.gov/pubmed/33408914
http://dx.doi.org/10.25259/SNI_233_2020

Ejemplares similares